Veradermics, Incorporated

formerly VeradermicsIPO

Dermatology and Aesthetics Solutions | Veradermics

Public · New Haven, United States · Founded 2019 · $262.2M raised

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$262.2M
Last Round
$150.0M Series COct 2025
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut, developing innovative therapeutics for pattern hair loss. Its lead asset, VDPHL01, is a potential non-hormonal oral treatment advancing through Phase 3 trials, including the first ever US trial for female pattern hair loss. The company listed on the NYSE under ticker MANE.

Summary

Veradermics, Incorporated is a Biotech company based in New Haven, United States, founded in 2019. It has raised $262.2M in total across 4 rounds, most recently a $150.0M Series C round in Oct 2025. Investors include SR One, Suvretta Capital Management and OrbiMed.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOFeb 2026
$256.3M

Sign up to see all 5 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Veradermics, Incorporated on Indexed.vc
<a href="https://indexed.vc/companies/veradermics-incorporated"><img src="https://indexed.vc/api/badge/company/veradermics-incorporated" alt="Veradermics, Incorporated on Indexed.vc" width="260" height="76" /></a>